COVID-19
TOOLBOX
Filter
10
Featured
Language
Document type
Guidelines
8
Manuals
1
Studies & Reports
1
Countries / Regions
Brazil
2
Russia
2
Mozambique
1
Latin America and the Carribbean
1
Kazakhstan
1
Belarus
1
Authors & Publishers
World Health Organization WHO
5
Organización Mundial de la Salud OMS
2
OPAS
1
Organización Mundial de Saude and OPAS
1
Polack, F.P. et al.
1
UNICEF
1
World Health Organisation (WHO)
1
Publication Years
Category
Countries
3
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no ... more
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below. fir ... more
Available in different languages
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at ... more
обновленная версия от 04/10/2021 Информация о введении вакцин
временные рекомендации от 8 января 2021 г. Available in Arabic, Chinese, English, French, Russian and Spanish here: https://apps.who.int/iris/handle/10665/338484
Vaccine handling, storage and Transportation of Pfizer BioNTech COVID-19 COMIRNATY® (Tozinameran)
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577